Interim Report 2019
Continued strong growth towards profitability Integumen (LSE: SKIN), the vertically [...]
How AI is Revolutionising Healthcare and Skin Disease
We have entered a new era where an Artificially Intelligent [...]
Cloning The Skin Microbiome On Labskin
Labskin breakthrough clones 16 human skin swabs into 54 living [...]
Wound pHase CBD Infused Chronic Woundcare and Burns Products
Integumen today announces the expansion of its wound care division, [...]
Trading Update H1 2019
Strong H1 2019 Revenue Growth Continues Trading Update The positive [...]
Final Results 2018
Integumen (LSE: SKIN), today announces its final results for the year [...]
3 Labskin contracts with CBD
Integumen today announces that Labskin AI, the virtual laboratory platform, [...]
Trading Update & Board Changes May 2019
Trading update – board changes Trading Update Integumen announces the [...]
Labskin Clones Human Skin Environment for Clinical Trials
Launch of Labskin human skin clone tests for Medical Device [...]
Appointment of Fionán Murray, as Group Sales Director
Fionán Murray has joined Integumen as Group Sales Director, and [...]